EyePoint Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
04.06.24
/
50%
€8.46
Target price
04.06.25
€29.43
Performance (%)
-3.81%
Price
27.08.24
€8.21
Summary
This prediction is currently active. With a performance of -3.81%, the BUY prediction for EyePoint Pharmaceuticals Inc. by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 04.06.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
EyePoint Pharmaceuticals Inc. | 15.304% | 15.304% |
iShares Core DAX® | 1.937% | 1.473% |
iShares Nasdaq 100 | -1.186% | -0.040% |
iShares Nikkei 225® | 1.938% | 4.205% |
iShares S&P 500 | -0.023% | 0.109% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at JPMorgan Chase & Co. from $35.00 to $32.00. They now have an "overweight" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.68
13.08.24
13.08.24
€26.50
13.08.25
13.08.25
6.93%
27.08.24
27.08.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.60
22.01.24
22.01.24
€32.12
22.01.25
22.01.25
-62.34%
27.08.24
27.08.24